Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO (patisiran), for the Treatment of ATTR Amyloidosis
Blackrock Announces Arrangements to Address Mailing of Meeting Materials Resulting from the Canada Post Strike
